RECENT NEWS

A new partnership between OGT, a global leader in genomic research and diagnostic solutions, and QIAGEN Digital Insights (QDI), a leading provider of genomic interpretation and analysis tools, expands OGT’s bioinformatics capabilities by integrating QIAGEN’s advanced tertiary analysis solution, QCI Interpret, with its SureSeq NGS panels.

Proscia, a pathology AI company, has announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data volumes and standardising siloed data.

The September issue of PIP has now been published and is available to read online.

A team of immunologists at the University of Massachusetts Amherst has discovered a pre-wired ability in ‘resting’ T cells to remember past viral foes, a promising breakthrough for targeted cancer therapies.

Genomics England has announced the appointment of Dr Natalie Banner as its Chief Ethics and Engagement Officer.

Scientists have developed a new test that can decode when a cancer tumour first started growing and how fast it is growing, potentially allowing doctors to accurately predict when a patient will need treatment.

A new report from The Royal College of Pathologists (RCPath) reveals that three-quarters of immunology services in the UK do not currently have enough staff to meet clinical demand.

A major trial supported by the University College London Hospitals Biomedical Research Centre aims to transform the diagnosis of Alzheimer’s disease through a simple blood test.

AI-powered digital pathology firm PathAI has announced new partnerships with AI pathology innovators Mindpeak, Stratipath, and Primaa. Artificial intelligence products from the three firms will soon be available via PathAI's AISight Dx image management system.

Sterilab Services, a leading supplier of diagnostic consumables in the UK, has been appointed as an authorised distributor for Copan, the globally recognised brand in microbiological specimen collection and transport.

A ground-breaking UK-wide scientific study will help improve the lives of future generations by studying 30,000 children born in 2026.

The Government has announced it is to roll out a new system of league tables for England’s NHS Trusts, as it aims to deliver better patient care following what it says is record investment.

A new report has shown that the UK can build a more preventive, efficient, and resilient healthcare system fit for the future by prioritising investment in in vitro diagnostics (IVDs) across the NHS.

Aiforia Technologies, a provider of deep learning AI solutions for digital pathology, has announced a strategic partnership with healthcare firm Siemens Healthineers, which aims to expand the availability of Aiforia’s AI-driven solutions across European diagnostic laboratories.

Proscia has announced the launch of Proscia Aperture, a pioneering precision medicine solution that automatically identifies candidates at the moment of diagnosis - addressing one of healthcare’s most critical challenges.

The Royal College of Pathologists (RCPath) has collaborated with The Royal College of Radiologists and other Medical Royal Colleges and associations to call for reform of multidisciplinary team meetings.

Radiometer, urgent and acute care testing specialist, will unite with Leica Biosystems and Cepheid at IBMS Congress 2025 to spotlight the breadth and scale of the Danaher Diagnostics portfolio.

Beckman Coulter Life Sciences is advancing nucleic acid quantification through a strategic collaboration with Hombrechtikon Systems Engineering, a Swiss provider of customised automation and engineering solutions for the life sciences and diagnostics sectors.

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering for pathology and radiology using Clinisys ICE.

Diagnostic technology firm Randox Laboratories has announced plans to expand its US site in Jefferson County, West Virginia, from a 48-person sales and distribution operation into a full-scale production laboratory, further increasing the company’s 4.1 billion annually manufactured tests.